{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:18:42Z","timestamp":1783149522504,"version":"3.54.6"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2026-25476348"],"award-info":[{"award-number":["RS-2026-25476348"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Korea Ministry of Science and ICT","doi-asserted-by":"publisher","award":["RS-2020-NR049559"],"award-info":[{"award-number":["RS-2020-NR049559"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bmc.2026.118675","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T23:36:20Z","timestamp":1776900980000},"page":"118675","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["3-Deoxy-4-sulfonamido-butein derivatives promote cell cycle arrest and apoptosis by inhibiting EGFR\/JAK2\/STAT3 signaling in A549 lung cancer cells"],"prefix":"10.1016","volume":"138","author":[{"given":"Jung Hwan","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Ha","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwon","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Uk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geon Wan","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yewon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joonseok","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-Hui","family":"Je","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong-Chan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Sung","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangjun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JinSeok","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hyoun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong-Gyu","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Yeol","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2026.118675_bb0005","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.phytol.2014.12.014","article-title":"Butein: from ancient traditional remedy to modern nutraceutical","volume":"11","author":"Semwal","year":"2015","journal-title":"Phytochem Lett"},{"key":"10.1016\/j.bmc.2026.118675_bb0010","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.phymed.2016.12.002","article-title":"Butein in health and disease: a comprehensive review","volume":"25","author":"Padmavathi","year":"2017","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bmc.2026.118675_bb0015","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/978-3-319-41334-1_17","article-title":"Butein and its role in chronic diseases","volume":"928","author":"Song","year":"2016","journal-title":"Adv Exp Med Biol"},{"issue":"13","key":"10.1016\/j.bmc.2026.118675_bb0020","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.phymed.2015.08.015","article-title":"Potential of butein, a tetrahydroxychalcone to obliterate cancer","volume":"22","author":"Padmavathi","year":"2015","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.bmc.2026.118675_bb0025","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1756-9966-33-51","article-title":"Butein suppresses breast cancer growth by reducing a production of intracellular reactive oxygen species","volume":"33","author":"Cho","year":"2014","journal-title":"J Exp Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.bmc.2026.118675_bb0030","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.bcp.2010.07.045","article-title":"Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-\u03baB activation in breast and pancreatic tumor cells","volume":"80","author":"Chua","year":"2010","journal-title":"Biochem Pharmacol"},{"issue":"10","key":"10.1016\/j.bmc.2026.118675_bb0035","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.7150\/jca.94546","article-title":"Butein inhibits oral squamous cell carcinoma growth via promoting MCL-1 ubiquitination","volume":"15","author":"Wang","year":"2024","journal-title":"J Cancer"},{"issue":"2","key":"10.1016\/j.bmc.2026.118675_bb0040","doi-asserted-by":"crossref","first-page":"763","DOI":"10.3892\/mmr.2013.1850","article-title":"Butein induces cell apoptosis and inhibition of cyclooxygenase-2 expression in a549 lung cancer cells","volume":"9","author":"Li","year":"2014","journal-title":"Mol Med Rep"},{"issue":"5","key":"10.1016\/j.bmc.2026.118675_bb0045","first-page":"414","article-title":"Chalcones as dietary cancer-preventive agents: structure\u2013activity relationship","volume":"7","author":"Li","year":"2007","journal-title":"Curr Cancer Drug Targets"},{"issue":"3","key":"10.1016\/j.bmc.2026.118675_bb0050","first-page":"150","article-title":"Role of catechol group in cytotoxic and antioxidant activities of butein derivatives","volume":"185","author":"Kang","year":"2010","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.bmc.2026.118675_bb0055","first-page":"297","article-title":"Butein, a novel anti-cancer agent: Chemopreventive and chemotherapeutic potential","volume":"10","author":"Yit","year":"2011","journal-title":"Phytochem Rev"},{"key":"10.1016\/j.bmc.2026.118675_bb0060","first-page":"225","article-title":"Catechol group is critical for anticancer activities of chalcones: SAR study","volume":"168","author":"Zhang","year":"2019","journal-title":"Eur J Med Chem"},{"issue":"17","key":"10.1016\/j.bmc.2026.118675_bb0065","first-page":"4218","article-title":"Catechol-containing chalcones induce apoptosis via ROS generation","volume":"24","author":"Wang","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"issue":"13","key":"10.1016\/j.bmc.2026.118675_bb0070","first-page":"1596","article-title":"Privileged structures as leads in medicinal chemistry","volume":"16","author":"Toma\u0161i\u0107","year":"2009","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bmc.2026.118675_bb0075","article-title":"Sulfonamides as a privileged scaffold in drug discovery: recent advances","volume":"213","author":"Ghorab","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2026.118675_bb0080","article-title":"Recent advances in sulfonamide-based drug design","volume":"239","author":"Zhang","year":"2022","journal-title":"Eur J Med Chem"},{"issue":"1","key":"10.1016\/j.bmc.2026.118675_bb0085","first-page":"9","article-title":"The early history of sulfa drugs","volume":"54","author":"Brown","year":"2010","journal-title":"Perspect Biol Med"},{"issue":"1","key":"10.1016\/j.bmc.2026.118675_bb0090","first-page":"1","article-title":"How many carbonic anhydrase inhibition mechanisms exist?","volume":"32","author":"Supuran","year":"2017","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"4","key":"10.1016\/j.bmc.2026.118675_bb0095","first-page":"385","article-title":"Structure\u2013activity relationships in sulfonamide-containing HIV-1 protease inhibitors","volume":"21","author":"Maccari","year":"2014","journal-title":"Curr Med Chem"},{"issue":"16","key":"10.1016\/j.bmc.2026.118675_bb0100","article-title":"Sulfonamide derivatives as anticonvulsants: design, synthesis, and biological evaluation","volume":"28","author":"Nafie","year":"2020","journal-title":"Bioorg Med Chem"},{"issue":"8","key":"10.1016\/j.bmc.2026.118675_bb0105","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1021\/jm1013693","article-title":"Privileged scaffolds for drug discovery: an update","volume":"54","author":"Meanwell","year":"2011","journal-title":"J Med Chem"},{"issue":"2","key":"10.1016\/j.bmc.2026.118675_bb0110","first-page":"1669","article-title":"Recent advances in therapeutic chalcones","volume":"14","author":"Ni","year":"2012","journal-title":"Expert Opin Ther Pat"},{"issue":"1","key":"10.1016\/j.bmc.2026.118675_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/157488410790410579","article-title":"Trends in utilization of the pharmacological potential of chalcones","volume":"5","author":"Batovska","year":"2010","journal-title":"Curr Clin Pharmacol"},{"issue":"6","key":"10.1016\/j.bmc.2026.118675_bb0120","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.3390\/molecules17066179","article-title":"Synthesis of chalcone derivatives and their anticancer properties: a review","volume":"17","author":"Syam","year":"2012","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bmc.2026.118675_bb0125","first-page":"715","article-title":"Chalcone: a privileged scaffold in drug discovery","volume":"19","author":"Khanam","year":"2015","journal-title":"Mol Divers"},{"issue":"9","key":"10.1016\/j.bmc.2026.118675_bb0130","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00894-022-05270-0","article-title":"Butein as a potential binder of human ACE2 receptor for interfering with SARS-CoV-2 entry: a computer-aided analysis","volume":"28","author":"Kapoor","year":"2022","journal-title":"J Mol Model"},{"issue":"10","key":"10.1016\/j.bmc.2026.118675_bb0135","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.3390\/molecules24101948","article-title":"An improved method for the synthesis of butein using SOCl2\/EtOH as catalyst and deciphering its inhibition mechanism on xanthine oxidase","volume":"24","author":"Hou","year":"2019","journal-title":"Molecules"},{"issue":"11","key":"10.1016\/j.bmc.2026.118675_bb0140","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.7150\/ijbs.25334","article-title":"Butein suppresses hepatocellular carcinoma growth via modulating aurora b kinase activity","volume":"14","author":"Zhou","year":"2018","journal-title":"Int J Biol Sci"},{"issue":"6","key":"10.1016\/j.bmc.2026.118675_bb0145","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3390\/90600387","article-title":"Self-associated, \u201cdistillable\u201d ionic media","volume":"9","author":"Kreher","year":"2004","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.bmc.2026.118675_bb0150","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.acthis.2018.02.005","article-title":"Tetrazolium salts and formazan products in cell biology: viability assessment, fluorescence imaging, and labeling perspectives","volume":"120","author":"Stockert","year":"2018","journal-title":"Acta Histochem"},{"issue":"5","key":"10.1016\/j.bmc.2026.118675_bb0155","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1038\/nprot.2006.339","article-title":"Clonogenic assay of cells in vitro","volume":"1","author":"Franken","year":"2006","journal-title":"Nat Protoc"},{"issue":"3","key":"10.1016\/j.bmc.2026.118675_bb0160","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1537-2995.2011.03305.x","article-title":"Flow cytometry assessment of apoptotic CD34+ cells by annexin v labeling may improve prediction of cord blood potency for engraftment","volume":"52","author":"Duggleby","year":"2012","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.bmc.2026.118675_bb0165","first-page":"6615","article-title":"Butein induces apoptotic cell death of human cervical cancer cells","volume":"16","author":"Yang","year":"2018","journal-title":"Oncol Lett"},{"key":"10.1016\/j.bmc.2026.118675_bb0170","series-title":"Regulators of Cell Cycle Progression","article-title":"The cell: a molecular approach","author":"Cooper","year":"2000"},{"issue":"8","key":"10.1016\/j.bmc.2026.118675_bb0175","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.7150\/ijbs.33790","article-title":"PERK\/eIF-2\u03b1\/CHOP pathway dependent ROS generation mediates butein-induced non-small-cell lung cancer apoptosis and G2\/M phase arrest","volume":"15","author":"Di","year":"2019","journal-title":"Int J Biol Sci"},{"issue":"6","key":"10.1016\/j.bmc.2026.118675_bb0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129851","article-title":"Resibufogenin induces G1-phase arrest through the proteasomal degradation of cyclin d1 in human malignant tumor cells","volume":"10","author":"Ichikawa","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.bmc.2026.118675_bb0185","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nrc.2016.138","article-title":"Cell cycle proteins as promising targets in cancer therapy","volume":"17","author":"Otto","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.bmc.2026.118675_bb0190","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3389\/fonc.2019.00800","article-title":"Rethink of EGFR in cancer with its kinase independent function on board","volume":"9","author":"Thomas","year":"2019","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.bmc.2026.118675_bb0195","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0021-9673(03)00207-3","article-title":"Selective separation of active inhibitors of epidermal growth factor receptor from caragana jubata by molecularly imprinted solid-phase extraction","volume":"991","author":"Zhu","year":"2003","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.bmc.2026.118675_bb0200","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4615-5873-6_7","article-title":"The functions of myc in cell cycle progression and apoptosis","volume":"2","author":"Steiner","year":"1996","journal-title":"Prog Cell Cycle Res"},{"issue":"24","key":"10.1016\/j.bmc.2026.118675_bb0205","doi-asserted-by":"crossref","first-page":"17340","DOI":"10.1074\/jbc.M700890200","article-title":"Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-kappaB and NF-kappaB-regulated gene expression through direct inhibition of IkappaBalpha kinase beta on cysteine 179 residue","volume":"282","author":"Pandey","year":"2007","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.bmc.2026.118675_bb0210","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s12859-023-05571-y","article-title":"CoDock-Ligand: combined template-based docking and CNN-based scoring in ligand binding prediction","volume":"24","author":"Pang","year":"2023","journal-title":"BMC Bioinform"},{"issue":"3","key":"10.1016\/j.bmc.2026.118675_bb0215","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ccr.2006.12.017","article-title":"Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity","volume":"11","author":"Yun","year":"2007","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.bmc.2026.118675_bb0220","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1021\/jm051197e","article-title":"MolDock: a new technique for high-accuracy molecular docking","volume":"49","author":"Thomsen","year":"2006","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118675_bb0225","series-title":"Chem3D 15.0 User Guide","author":"PerkinElmer Informatics","year":"2014"},{"issue":"20","key":"10.1016\/j.bmc.2026.118675_bb0230","first-page":"5749","article-title":"ZD1839 (iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy","volume":"62","author":"Wakeling","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.bmc.2026.118675_bb0235","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/1471-2407-6-277","article-title":"Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of akt without ligand stimulation","volume":"6","author":"Noro","year":"2006","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.bmc.2026.118675_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2019.10.002","article-title":"A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo","volume":"36","author":"Bai","year":"2019","journal-title":"Cancer Cell"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626001318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626001318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:52:46Z","timestamp":1783147966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626001318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":48,"alternative-id":["S0968089626001318"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118675","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3-Deoxy-4-sulfonamido-butein derivatives promote cell cycle arrest and apoptosis by inhibiting EGFR\/JAK2\/STAT3 signaling in A549 lung cancer cells","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118675","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118675"}}